Professor Doug Altman
Study and Trial Design Theme Lead, NIHR Diagnostic Evidence Co-operative Leeds


Professor Altman is Professor of Statistics in Medicine in Oxford. He currently directs the Centre Statistics in Medicine in Oxford and is Co-Director of the Oxford Clinical Trials Research Unit. His research has been supported by Cancer Research UK since 1988. He has authored over 600 publications including many aimed at improving understanding of statistics by clinicians and medical researchers. His major research interests include randomised trials, studies of prognosis, studies of medical measurements, and systematic reviews. He is a member of the executive of the CONSORT Group, which produced the CONSORT Statement, a guideline for reporting the methods and results of randomised controlled trials. He has been involved in the development of several other reporting guidelines, including REMARK (for tumour marker prognostic studies), STROBE (for observational studies), and PRISMA (for systematic reviews). He is co-founder of the international EQUATOR Network (Enhancing the QUAlity and Transparency Of health Research). He is senior statistics editor at the British Medical Journal and co-editor in chief of Trials. In 1997 he received the Bradford Hill Medal for his contributions to medical statistics and a DSc from the University of London. He is an NIHR Senior Investigator and a fellow of the Academy of Medical Sciences.